Mumbai, Maharashtra, India, April 2026 — Krishnakumar N has started a new role at Ferring Pharmaceuticals as Director, External Manufacturing Network, Operational Stream Lead, where he will be leading the operational stream for the Asian region. This appointment marks an important milestone in his pharmaceutical leadership journey and reflects his deep experience across external manufacturing, supplier relationship management, quality assurance, biopharma operations, and technical operations.
Before joining Ferring Pharmaceuticals, Krishnakumar N spent nearly fourteen years with Sandoz, where he held key leadership roles including Head External Supplier Relationship Management, Sandoz Biologics and Head TechOps India Biopharma BU. These roles reflect a strong progression across biopharma operations, external manufacturing oversight, technical operations, regulatory coordination, and biosimilar commercialization.
Earlier, he was associated with Novartis India in Quality Assurance, where he managed quality-related activities across external suppliers and global audit coordination. Prior to that, he worked with Serum Institute of India Pvt. Ltd. as Sr. Manager Quality Assurance, with Baxter as Site Quality Head, and with sanofi-aventis in roles including Executive Quality Assurance and Manufacturing Executive. These assignments reflect a strong and sustained career across quality systems, manufacturing, validation, compliance, and regulated market operations.
In the earlier phase of his professional journey, Krishnakumar N was associated with Cadila Pharmaceuticals as Sr. Technical Supervisor and with Hoechst as Graduate Apprentice, Manufacturing. Academically, he studied at the Birla Institute of Technology and Science, Pilani. Together, his experience across Ferring Pharmaceuticals, Sandoz, Novartis India, Serum Institute of India Pvt. Ltd., Baxter, sanofi-aventis, Cadila Pharmaceuticals, and Hoechst reflects a long and accomplished leadership journey in the pharmaceutical and biopharmaceutical industry.
With extensive experience across external manufacturing networks, supplier governance, biopharma operations, quality systems, and regulatory support, Krishnakumar N brings a strong and well-rounded profile to his new role. His appointment is expected to support Ferring Pharmaceuticals as it continues to strengthen its operational stream and manufacturing network across Asia.
About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a privately owned, research-driven, specialty biopharmaceutical group committed to building families and helping people live better lives. The company is a leader in reproductive medicine, maternal health, gastroenterology, and urology, and is also advancing innovation in microbiome-based therapeutics and uro-oncology intravesical gene therapy. Founded in 1950, Ferring employs more than 7,000 people worldwide and operates in more than 50 countries, with its medicines marketed in over 100 countries.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
